Lv656
3060 积分 2022-05-05 加入
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
3天前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
4天前
已完结
LBA30 ATHENA-COMBO, a phase III, randomized trial comparing rucaparib (RUCA) + nivolumab (NIVO) combination therapy vs RUCA monotherapy as maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC)
10天前
已关闭
Interim post-progression data and updated survival in patients with newly diagnosed advanced ovarian cancer in ATHENA-MONO
10天前
已完结
Chemotherapy With Or Without Pembrolizumab Followed By Maintenance With Olaparib Or Placebo For First-Line Treatment Of Advanced BRCA Non-Mutated Epithelial Ovarian Cancer: Results From The Randomized Phase 3 ENGOT-OV43/GOG-3036/KEYLYNK-001 Study
16天前
已关闭
Candidate Biomarker of Response to Immunotherapy In Small Cell Lung Cancer
16天前
已完结
Top advances of the year: Small cell lung cancer
16天前
已完结
Interim post-progression data and updated survival in patients with newly diagnosed advanced ovarian cancer in ATHENA-MONO
17天前
已完结
LBA30 ATHENA-COMBO, a phase III, randomized trial comparing rucaparib (RUCA) + nivolumab (NIVO) combination therapy vs RUCA monotherapy as maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC)
17天前
已关闭
EV311/#1193 First-line rucaparib maintenance after hyperthermic intraperitoneal chemotherapy with interval debulking surgery for advanced epithelial ovarian cancer: a real-world study
17天前
已关闭
皖公网安备34019202002308
